Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1939: OCT and Embolic Protection Synergy in Carotid Revascularization: Technical and Clinical Insights From a Recurrent CVA Case

Presenter: Sumit Bhatnagar

October 26, 2025

Presentation NY Valves 2025

MIRVAD (Mitral Repair Under Ventricular Assist Device): A Planned cVAD Strategy for High-Risk Secondary Mitral TEER

Presenter: Guillaume Bonnet

June 27, 2025

Presentation TCT 2024

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Presenter: Batla Falah

October 28, 2024

Presentation TCT 2024

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

Presenter: Batla Falah

October 27, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

Presentation TCT 2023

TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study

Presenter: Batla Falah

October 26, 2023

Presentation TCT 2023

TCT 214: Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Presenter: Karl-Philipp Rommel

October 26, 2023

Presentation TCT 2023

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

Presenter: Guillaume Bonnet

October 26, 2023

Presentation TCT 2023

TCT 143: Prognostic Implications of Anemia in Impella-Supported HRPCI: Insights From the cVAD PROTECT III Study

Presenter: Batla Falah

October 26, 2023

News Daily News

Reports of Arrhythmias, Cardiac Arrests Linked to Nonprescription Opioids

Todd Neale

June 09, 2023

News Daily News

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

Caitlin E. Cox

August 16, 2021

Presentation CACI 2019

ACV en Argentina Datos poblacionales

Presenter: Sebastián F. Ameriso

November 29, 2019

Presentation TCT 2019

Protected PCI: A Contemporary Look at Clinical Data from cVAD

Presenter: Jeffrey Popma

September 26, 2019

News Daily News

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Michael O'Riordan

May 13, 2019

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Daily News

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Todd Neale

February 13, 2018

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

Presentation CHIP Florida 2017

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Presenter: Jonathan Scharfstein

January 20, 2017

Advertisement

TCT 1939: OCT and Embolic Protection Synergy in Carotid Revascularization: Technical and Clinical Insights From a Recurrent CVA Case

MIRVAD (Mitral Repair Under Ventricular Assist Device): A Planned cVAD Strategy for High-Risk Secondary Mitral TEER

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

Experts Warn of Looming Private Equity Interest in Cardiology Care

TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study

TCT 214: Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

TCT 143: Prognostic Implications of Anemia in Impella-Supported HRPCI: Insights From the cVAD PROTECT III Study

Reports of Arrhythmias, Cardiac Arrests Linked to Nonprescription Opioids

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

ACV en Argentina Datos poblacionales

Protected PCI: A Contemporary Look at Clinical Data from cVAD

Bariatric Surgery Linked to Survival Advantage After MI and CVA

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content